The store will not work correctly when cookies are disabled.
4'-[(5-Methylhexyl)oxy][1,1'-biphenyl]-4-carboxylic acid
ID: ALA469281
PubChem CID: 15951927
Max Phase: Preclinical
Molecular Formula: C20H24O3
Molecular Weight: 312.41
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)CCCCOc1ccc(-c2ccc(C(=O)O)cc2)cc1
Standard InChI: InChI=1S/C20H24O3/c1-15(2)5-3-4-14-23-19-12-10-17(11-13-19)16-6-8-18(9-7-16)20(21)22/h6-13,15H,3-5,14H2,1-2H3,(H,21,22)
Standard InChI Key: KAMPGBXWQOLHJJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 24 0 0 0 0 0 0 0 0999 V2000
16.8791 -4.6824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5935 -5.1015 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3066 -4.6897 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3094 -3.8629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6012 -3.4516 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8839 -3.8592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1618 -5.0942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4494 -4.6787 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7322 -5.0905 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7273 -5.9136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4418 -6.3286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1590 -5.9210 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0266 -3.4553 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0315 -2.6321 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.7411 -3.8703 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.0101 -6.3213 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.2977 -5.9099 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5805 -6.3176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8702 -5.9026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1529 -6.3103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4386 -5.8954 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4414 -5.0686 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7213 -6.3030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
1 6 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
7 12 2 0
1 7 1 0
13 14 2 0
13 15 1 0
4 13 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
21 23 1 0
16 17 1 0
10 16 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 312.41 | Molecular Weight (Monoisotopic): 312.1725 | AlogP: 5.26 | #Rotatable Bonds: 8 |
Polar Surface Area: 46.53 | Molecular Species: ACID | HBA: 2 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 4.08 | CX Basic pKa: ┄ | CX LogP: 5.62 | CX LogD: 2.51 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.68 | Np Likeness Score: -0.12 |
References
1. Lund BW, Knapp AE, Piu F, Gauthier NK, Begtrup M, Hacksell U, Olsson R.. (2009) Design, synthesis, and structure-activity analysis of isoform-selective retinoic acid receptor beta ligands., 52 (6): [PMID:19239230] [10.1021/jm801532e] |